TrialLancet (London, England)2016

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

John F Forbes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.